Search Results
Results for: LIGAND PHARMACEUTICALS (Save this search)
Number of Results: 10
Ligand Closes GBP 32.8m Acquisition of UK Structure-Based Drug Discovery Specialist Vernalis
11 October 2018 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has closed the acquisition of the entire issued and to be issued shares of UK-based Vernalis pl...

LIGAND CLOSES GBP 32.8M ACQUISITION OF UK STRUCTURE-BASED DRUG DISCOVERY SPECIALIST VERNALIS
US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has closed the acquisition of the entire issued and to be issued shares of UK-based Vernalis plc (LSE: VER) throu...

Ligand Makes Offer to Acquire UK Structure-Based Drug Discovery Specialist Vernalis for GBP 32.8m
10 August 2018 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has declared its firm intention to acquire the entire issued and to be issued shares of UK-based...

Ligand to Acquire Antibody Generation Specialist Crystal Bioscience for USD 25m in Cash plus Earnouts
5 October 2017 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) and antibodies generator Crystal Bioscience, Inc. have signed a merger agreement whereby Li...

Ligand Agrees to Acquire Genetic Engineering Company OMT for USD 178m
18 December 2015 - US-based biotechnology company Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has signed an agreement to acquire US-based genetic engineering company OMT, Inc.&...

LIGAND AGREES TO ACQUIRE GENETIC ENGINEERING COMPANY OMT FOR USD 178M
US-based biotechnology company Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has signed an agreement to acquire US-based genetic engineering company OMT, Inc. (Open Monoclon...

US LIGAND STRIKES DEAL TO BUY CYDEX PHARMACEUTICALS
US biotechnology company Ligand Pharmaceuticals (NASDAQ:LGND) said it has taken over Kansas-based CyDex Pharmaceuticals in a cash and contingent payments agreement....

US Ligand strikes deal to buy CyDex Pharmaceuticals
US biotechnology company Ligand Pharmaceuticals (NASDAQ:LGND) said it has taken over Kansas-based CyDex Pharmaceuticals in a cash and contingent payments agreement.The owners of Cy...

US LIGAND CLOSES METABASIS PURCHASE
US biotechnology company Ligand Pharmaceuticals (NASDAQ:LGND) said it has closed the purchase of biopharmaceutical group Metabasis Therapeutics (NASDAQ:MBRX) for USD1.6m (EUR1.1m) ...

You can compare news articles by clicking on the tick buttons
1